|Bid||15.60 x 800|
|Ask||15.83 x 900|
|Day's Range||15.65 - 15.95|
|52 Week Range||9.60 - 26.81|
|Beta (5Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020 - Nov 12, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.40|
LNDC earnings call for the period ending May 31, 2020.
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -3.39% and 38.64%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]